3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
rozanolixizumab
5
zilucoplan
4
eculizumab
4
Rituximab
4
Immunoglobulins, Intravenous
4
efgartigimod alfa
3
Tacrolimus
3
Mycophenolic Acid
3
Hizentra
3
HBM9161
3
Data Collection
2
Azathioprine
2
tofacitinib
1
telitacicept
1
ravulizumab
1
iscalimab
1
gamma-Globulins
1
apraclonidine
1
Thymectomy
1
Telemedicine
1
Sugammadex
1
Sodium Chloride
1
Pyridostigmine Bromide
1
Prednisone
1
Prednisolone
1
Plasmapheresis
1
Plasma Exchange
1
Neurofeedback
1
Neostigmine
1
Muscle Stretching Exercises
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myasthenia Gravis
×
Exercise
×
Clear all
NCT05992025
2025-03-30
DIG-MG
Uppsala University
Phase NA
Completed
83 enrolled